Trial Profile
Eszopiclone in the treatment of insomnia and associated symptoms of fibromyalgia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Fibromyalgia; Insomnia
- Focus Therapeutic Use
- 09 Feb 2010 Actual end date (1 Mar 2009) added as reported by ClinicalTrials.gov record.
- 09 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Jun 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.